Olian Judy D.'s Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 8, 2022
- Accession no.
- 0001415889-22-011203
- Filed
- Nov 8, 2022
- Trade date
- Nov 7-8, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $159.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olian Judy D.CIK 0001605729 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Common Stock | GGiftDisposed | −1,125 | –F1 | – | 9,265 | Direct | |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −600 | $265.09 | −$159,054 | 8,665 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Bona fide charitable contribution to a donor advised fund.
Referenced by the price of 1 transaction in Table I.